Application Now Closed
Purpose:
The intent of this award — which is supported by the Journal of Surgical Research and its publisher, Elsevier Science — is to provide early-career research support to junior faculty members of the AAS.
Eligibility:
-
- Applicants must be full-time faculty who have not yet attained the rank of Associate Professor
- Faculty in any surgical specialty or discipline are eligible
- Applicants must be active members of the AAS
- The awardee must not be a principal investigator on a NIH R01 or a VA Merit Review Grant and may not hold a career development type of award. This proposal may be submitted to other funding sources for support, but this must be acknowledged on the application form. Submission for support elsewhere will not affect the evaluation of this proposal.
Funding and Reporting Requirements:
The funding period: May 1st 2025 – April 30th 2026
Committee Review
A committee, consisting of the councilors of the AAS, president-elect, and ad-hoc members as needed, will review all proposals. The top-rated proposals will be selected as finalists, and these applicants will be invited to interview with the selection committee. The award recipient will be selected from these finalists and will be announced at the AAS Research Awards Ceremony.
Acceptance of Award
The winner will receive $50,000 for one year to be used for direct-cost expenditures incurred in the conduct of the proposed research project; the award may not be used for salary support. The project must be completed within the 1 year funding period. In the event that investigator is awarded another extramural award for which there is scientific or budgetary overlap with the other grant/award, the investigator will be required to accept only one source of funding. No indirect costs will be covered. The award certificate will be presented at the AAS/SUS Awards Ceremony during the 2025 Academic Surgical Congress. A one-page formal progress report for the research project and copies of pertinent publications resulting from the funding of the research award should be forwarded to the AAS office upon completion of the one-year research project. A final report and presentation of work accomplished will be required at the 2026 Academic Surgical Congress following the conclusion of the grant. No more than 10% of the funding may be used for travel – these funds will be expected to cover the cost of the awardee ASC presentation requirement.
APPLICATION PROCESS
Applications must be submitted using the online submission site which will close Friday, August 30th, 2024 at 11:59 PM Pacific Time.
Part 1: General information
Complete the General Information section, which includes your contact information, Institution information, etc.
Part 2: Project information
Complete the project information section, which includes project title, alternate funding sources, mentor information, etc.
Part 3: Supporting Documents
ALL DOCUMENTS MUST BE UPLOADED AS ONE FILE IN PDF FORMAT (REQUIRED). Grants which are incomplete or do not follow the page limits or formatting guidelines will not be reviewed. Applicants submit the following materials:
- Cover Letter (Limit: 1 page) – Must outline your career development plan, short and long-term career goals, and plans for interacting with their mentors/collaborators
- NIH-style Biosketch (Limit: 5 pages)
- Comprehensive Research Plan (Limit: 5 pages) single-spaced, Arial 11pt, 1″ margin, excluding references. Must include:
- abstract for research proposal
- significance of research
- background information
- preliminary observations
- experimental plan (methods, materials, potential limitations and pitfalls)
- Budget (Limit: 1 page) – Brief budget justification. Must include 10% use for travel (see funding parameters listed above)
- Letter from Sponsoring Research Mentor (Limit: 2 pages)
- Letter of Support from the Chair of your Department (Limit: 2 pages) – The letter should also state that the award will not be used for salary support for the recipient
Applications which exceed the page limitations WILL NOT BE REVIEWED.
APPLICATION NOW CLOSED
Previous Award Winners:
2025 Jessica McMullin, MD, University of Utah “The Cost Effectiveness of Screening Incidentalomas and Implementing Interventions to Improve Care”
2024 Alison Smith, MD Louisiana State University “Mechanisms of Alcohol-Induced Immunometabolic Dyshomeostasis of Adipose-Derived Stem Cells following Major Injury”
2023 Sarah Tevis, MD, University of Colorado School of Medicine “Development and Evaluation of a Novel Educational Intervention to Improve Conversations about Breast Surgery in Women with Breast Cancer”
2022 Anne Ehlers, MD, University of Michigan “Clinical And Patient-Reported Outcomes Of Females With Groin Hernia”
2021 Jashodeep Datta, MD, University of Miami Miller School of Medicine “Reprogramming tolerogenic signaling in myeloid derived suppressor cells by targeting tumor-intrinsic Cxcl1 in Ras-p53 cooperative pancreatic cancer”
2020 Sepideh Gholami, MD, University of California, Davis “Investigation of RAS Mutation and Immune Cell Trafficking in Colorectal Liver Metastases on an Ex-vivo 3D-Chip”
2019 Rony Marwan, MD, University of Colorado Denver “Heterogeneous Pulmonary Response to Tracheal Occlusion: Structural Implications”
2018 Filip Bednar, University of Michigan “Transcriptional and Epigenetic Regulation of Early Pancreatic Neoplasia by Bmi1”
2017 Christopher Pannucci, University of Utah “The impact of real-time anti-Factor Xa measurement and enoxaparin dose adjustment in surgical patients who receive enoxaparin prophylaxis”
2016 J. Joshua Smith, Memorial Sloan Kettering Cancer Center “Utilization of a Smad4-modulated gene expression profile to identify small molecules/compounds that recapitulate the tumor suppressor effects of Smad4 and predict chemoresistance in colorectal cancer patients”
2015 Benjamin Levy, MD, University of Michigan “Targeting heterotopic ossification induced joint contractures before they occur through early detection and angiogenic inhibition”
2014 Colin Martin, MD, University of Alabama-Birmingham “A Novel Role of AhR Mediated Intestinal Injury in Neonates”
2013 Kevin P. Mollen, MD, Children’s Hospital of Pittsburg “The Role of Dysfunctional Mitochondrial Biogenesis in the Pathogenesis of Experimental Colitis”
2011 Timothy Donahue, MD, UCLA “Influence of SRC Signaling on Human Pancreatic Cancer Progression”
2009 Michael Lim, MD, Johns Hopkins University School of Medicine “Characterization of STAT3 in GBM: A Potential Mediator of Immune Evasion”
2007 Eric T. Kimchi, MD, Penn State College of Medicine/Hershey Medical Center “Overcoming Tumor-antigen Specific Tolerance in a Spontaneous Murine Hepatocellular Model”
2005 Julie Ann Sosa, MD, Yale University School of Medicine “Effects of Parathyroidectomy on Neurocognitive Function in Primary Hyperparathyroidism”
2003 Omaida C. Velasquez, MD, University of Miami “The Role of Bone Marrow-derived Endothelial Cells in Vassculogenesis”
2001 Neri M. Cohen, MD, PhD, Greater Baltimore Medical Center
2000 Anthony D. Sandler, MD, Children’s National Medical Center